These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35171086)

  • 21. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
    Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
    Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm.
    Boni C; Cavazzini D; Bolchi A; Rossi M; Vecchi A; Tiezzi C; Barili V; Fisicaro P; Ferrari C; Ottonello S
    Front Immunol; 2021; 12():730051. PubMed ID: 34566990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ad5-nCoV Vaccination Could Induce HLA-E Restricted CD8
    Wang Y; Yang L; Tang K; Zhang Y; Zhang C; Zhang Y; Jin B; Zhang Y; Zhuang R; Ma Y
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides.
    Hikichi T; Sakamoto M; Harada M; Saito M; Yamane Y; Tokumura K; Nakamura Y
    J Hum Genet; 2022 Jul; 67(7):411-419. PubMed ID: 35110673
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Devi A; Chaitanya NSN
    J Biomol Struct Dyn; 2021 Nov; 39(18):6903-6917. PubMed ID: 32772892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein.
    Martin WR; Cheng F
    J Biomol Struct Dyn; 2022 Sep; 40(15):7099-7113. PubMed ID: 33715598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.
    Guo E; Guo H
    PLoS One; 2020; 15(12):e0239566. PubMed ID: 33301503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
    Oliveira SC; de Magalhães MTQ; Homan EJ
    Front Immunol; 2020; 11():587615. PubMed ID: 33193414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8+ T cell reactivity and also signs of immune response escape.
    Pretti MAM; Galvani RG; Scherer NM; Farias AS; Boroni M
    Infect Genet Evol; 2022 Apr; 99():105236. PubMed ID: 35149224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools.
    Prachar M; Justesen S; Steen-Jensen DB; Thorgrimsen S; Jurgons E; Winther O; Bagger FO
    Sci Rep; 2020 Nov; 10(1):20465. PubMed ID: 33235258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential epitope prediction across diverse circulating variants of SARS-COV-2 in Brazil.
    Cavalcanti-Dantas VM; Fernandes B; Dantas PHLF; Uchoa GR; Mendes AF; Araújo Júnior WO; Castellano LRC; Fernandes AIV; Goulart LR; Oliveira RADS; Assis PAC; Souza JR; Morais CNL
    Comput Biol Chem; 2024 Oct; 112():108139. PubMed ID: 38972100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.
    Feola S; Chiaro J; Fusciello M; Russo S; Kleino I; Ylösmäki L; Kekäläinen E; Hästbacka J; Pekkarinen PT; Ylösmäki E; Capone S; Folgori A; Raggioli A; Boni C; Tiezzi C; Vecchi A; Gelzo M; Kared H; Nardin A; Fehlings M; Barban V; Ahokas P; Viitala T; Castaldo G; Pastore L; Porter P; Pesonen S; Cerullo V
    Int J Biol Macromol; 2024 Mar; 262(Pt 1):129926. PubMed ID: 38331062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine.
    Shehata MM; Mahmoud SH; Tarek M; Al-Karmalawy AA; Mahmoud A; Mostafa A; M Elhefnawi M; Ali MA
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoinformatics Identification of the Conserved and Cross-Reactive T-Cell Epitopes of SARS-CoV-2 with Human Common Cold Coronaviruses, SARS-CoV, MERS-CoV and Live Attenuated Vaccines Presented by HLA Alleles of Indonesian Population.
    Gustiananda M; Julietta V; Hermawan A; Febriana GG; Hermantara R; Kristiani L; Sidhartha E; Sutejo R; Agustriawan D; Andarini S; Parikesit AA
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 epitopes inform future vaccination strategies.
    Shafqat A; Omer MH; Ahmad O; Niaz M; Abdulkader HS; Shafqat S; Mushtaq AH; Shaik A; Elshaer AN; Kashir J; Alkattan K; Yaqinuddin A
    Front Immunol; 2022; 13():1041185. PubMed ID: 36505475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern.
    Martín-Galiano AJ; Díez-Fuertes F; McConnell MJ; López D
    Front Immunol; 2021; 12():732693. PubMed ID: 34899692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.